Leukocyte telomere length is associated with disability in older U.S. population

Telomeres » Institutional Study » Leukocyte telomere length is associated with disability in older U.S. population

March 21, 2017 | Amy | Leave a comment

Peer-Reviewed Scientific Journal:
Journal of the American Geriatric Society

Size of study:
624 adults

Summary
This study found that leukocyte telomere length is predictive of disability of older individuals in the U.S. population. Diabetes mellitus in particular plays an important role as a modifier of the association between leukocyte telomere length and disability, CVD, and cancer. These findings suggest that leukocyte telomere length can be a clinically viable biomarker of overall well-being that is predictive of morbidity in older U.S. adults.

Link to study

SEE THE FULL STUDY

Leave a Reply Cancel reply

The TeloYears test is not intended for screening, diagnosing, treating or preventing diseases or medical conditions. The TeloYears genetic test may indicate the possibility of identifying a rare telomere syndrome associated with extremely shorter or longer average telomere length (ATL). In these rare cases, further testing and consultation with a doctor to rule in or rule out a telomere syndrome is recommended. The test is available for individuals between the ages of 20 to 80 within the United States, except for the states of Maryland and New York. The information provided by the TeloYears test should not be used to replace medically appropriate screening tests recommended based upon actual age or other risk factors, nor should the information be used to make decisions about diagnosis or treatment of diseases or medical conditions. The Telomere Diagnostics lab is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by Telomere Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration.